Twr Lee

Summary

Country: UK

Publications

  1. ncbi Routine neonatal examination: effectiveness of trainee paediatrician compared with advanced neonatal nurse practitioner
    T W Lee
    Department of Paediatrics, Hull and East Yorkshire Hospitals NHS Trust, Anlaby Road, Hull HU3 2JZ, UK
    Arch Dis Child Fetal Neonatal Ed 85:F100-4. 2001
  2. ncbi Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease
    Tim W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Centre, Children s Day Hospital, St James s University Hospital, Leeds, UK
    Cochrane Database Syst Rev 10:CD005599. 2012
  3. ncbi Adenovirus core protein VII contains distinct sequences that mediate targeting to the nucleus and nucleolus, and colocalization with human chromosomes
    Tim W R Lee
    School of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK
    J Gen Virol 84:3423-8. 2003
  4. ncbi Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center
    Tim W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Unit, St James s University Hospital, Leeds, United Kingdom
    Pediatr Pulmonol 37:104-10. 2004
  5. ncbi Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients
    Tim W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Centre, St James s Hospital, Leeds, UK
    J Cyst Fibros 2:29-34. 2003
  6. ncbi Novel molecular approaches to cystic fibrosis gene therapy
    Tim W R Lee
    School of Biochemistry and Microbiology, University of Leeds, Leeds LS2 9JT, UK
    Biochem J 387:1-15. 2005
  7. ncbi Respiratory exacerbations in childhood associated with compound heterozygosity Phe508del/Arg117His-7T of the cystic fibrosis transmembrane regulator gene
    T W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Centre, St James s University Hospital, Leeds, United Kingdom
    Acta Paediatr 97:670-2. 2008
  8. ncbi Eradication of early Pseudomonas infection in cystic fibrosis
    T W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Centre, Childrens Day Hospital, St James s University Hospital, Leeds, UK
    Chron Respir Dis 6:99-107. 2009
  9. ncbi Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism
    Sheng Ang Ho
    Department of Paediatrics, Macclesfield General Hospital, Macclesfield, SK10 3BL, UK
    J Cyst Fibros 8:43-6. 2009

Detail Information

Publications9

  1. ncbi Routine neonatal examination: effectiveness of trainee paediatrician compared with advanced neonatal nurse practitioner
    T W Lee
    Department of Paediatrics, Hull and East Yorkshire Hospitals NHS Trust, Anlaby Road, Hull HU3 2JZ, UK
    Arch Dis Child Fetal Neonatal Ed 85:F100-4. 2001
    ..To compare the effectiveness of routine neonatal examination performed by senior house officers (SHOs) and advanced neonatal nurse practitioners (ANNPs)...
  2. ncbi Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease
    Tim W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Centre, Children s Day Hospital, St James s University Hospital, Leeds, UK
    Cochrane Database Syst Rev 10:CD005599. 2012
    ....
  3. ncbi Adenovirus core protein VII contains distinct sequences that mediate targeting to the nucleus and nucleolus, and colocalization with human chromosomes
    Tim W R Lee
    School of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK
    J Gen Virol 84:3423-8. 2003
    ..Furthermore, the data suggest that protein VII may bind to human chromosomes by means of two distinct domains, one sharing homology with the N-terminal regulatory tail of histone H3...
  4. ncbi Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center
    Tim W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Unit, St James s University Hospital, Leeds, United Kingdom
    Pediatr Pulmonol 37:104-10. 2004
    ..aeruginosa did not alter significantly. In conclusion, antipseudomonal management strategies were associated with both reduced prevalence, and an increase in the mean age of onset of chronic P. aeruginosa infection...
  5. ncbi Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients
    Tim W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Centre, St James s Hospital, Leeds, UK
    J Cyst Fibros 2:29-34. 2003
    ....
  6. ncbi Novel molecular approaches to cystic fibrosis gene therapy
    Tim W R Lee
    School of Biochemistry and Microbiology, University of Leeds, Leeds LS2 9JT, UK
    Biochem J 387:1-15. 2005
    ..Much progress in this area has been informed by advances in our understanding of the mechanisms by which viruses deliver their genomes to the nuclei of host cells...
  7. ncbi Respiratory exacerbations in childhood associated with compound heterozygosity Phe508del/Arg117His-7T of the cystic fibrosis transmembrane regulator gene
    T W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Centre, St James s University Hospital, Leeds, United Kingdom
    Acta Paediatr 97:670-2. 2008
    ..Conclusion: The compound heterozygote cystic fibrosis (CF) mutation Phe508del with Arg117His-7T should not necessarily be considered benign in childhood...
  8. ncbi Eradication of early Pseudomonas infection in cystic fibrosis
    T W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Centre, Childrens Day Hospital, St James s University Hospital, Leeds, UK
    Chron Respir Dis 6:99-107. 2009
    ..The most effective antibiotic regimen, and the effects of new nebulizer technologies and methods to improve concordance remain to be determined...
  9. ncbi Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism
    Sheng Ang Ho
    Department of Paediatrics, Macclesfield General Hospital, Macclesfield, SK10 3BL, UK
    J Cyst Fibros 8:43-6. 2009
    ..This study was designed to address the concern that intensive regimens to eradicate early Pseudomonas aeruginosa infection in patients with cystic fibrosis may lead to the emergence of antibiotic-resistant isolates...